Money
Traders on CNBC’s Fast Money discussed their picks for Wednesday, December 3. Tim Seymour thinks transports have been unfairly punished and he would buy...
Hi, what are you looking for?
Traders on CNBC’s Fast Money discussed their picks for Wednesday, December 3. Tim Seymour thinks transports have been unfairly punished and he would buy...
On CNBC’s Mad Dash segment, Jim Cramer discussed “one of my favorite stocks, ” Zoetis, an animal health drug company spun off by Pfizer....
On CNBC’s Mad Dash, Jim Cramer discussed Zoetis, an animal health biotech, that is a “gem of a company” spun off by Pfizer....
– Ken Fisher is one of the most successful money managers around; for the year, his holdings increased in value from $44.3 billion to...
– Teva Receives Favorable Court Decision Regarding Generic Celebrex® Capsules; Teva Should Receive Sole Exclusivity for Generic Celebrex Capsules. – – Teva Pharmaceutical Industries...
– / By Alan Gallindoss/ On June 12th Jewish Business News reported that Teva had settled a major lawsuit brought against it by Pfizer...
– /By Itzhak Dannon / As we have recently reported, Pfizer, the world’s largest pharmaceutical company filed, over a month ago, a civil suit against...
– The UK price of the impotence treatment, which costs the National Health Service £40 million annually, is expected to fall from £10 to...
– – / By Alan Gallindoss / Global pharmaceutical company Pfizer announced today that Israeli company Teva Pharmaceuticals Industries and Indian generic drug manufacturer...
– Novocure CEO Asaf Danziger says the company will remain independent, despite interest from big pharma. – – /By Gali Weinreb / Novocure Ltd....